carbapenems has been researched along with 7432 s in 3 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (7432 s) | Trials (7432 s) | Recent Studies (post-2010) (7432 s) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 235 | 49 | 23 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dornbusch, K; Göransson, E; Kronvall, G; Mörtsell, E | 1 |
| Verbist, L; Verhaegen, J | 1 |
| Castanheira, M; Mendes, RE; Rhomberg, PR; Watters, AA | 1 |
3 other study(ies) available for carbapenems and 7432 s
| Article | Year |
|---|---|
In-vitro activity of FCE 22101 against respiratory tract pathogens with reference to production of beta-lactamases.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Carbapenems; Ceftibuten; Cephalosporins; Imipenem; Microbial Sensitivity Tests; Respiratory Tract Infections | 1989 |
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae | 1998 |
In vitro activity of the orally bioavailable ceftibuten/VNRX-7145 (VNRX-5236 etzadroxil) combination against a challenge set of Enterobacterales pathogens carrying molecularly characterized β-lactamase genes.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Ceftibuten; Microbial Sensitivity Tests | 2022 |